Molecular interactions between glucocorticoids and long-acting beta2-agonists.
about
Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatasesThe synergistic anti-asthmatic effects of glycyrrhizin and salbutamol.Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy.A long-acting β2-adrenergic agonist increases the expression of muscarine cholinergic subtype‑3 receptors by activating the β2-adrenoceptor cyclic adenosine monophosphate signaling pathway in airway smooth muscle cellsEffect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial.Overview of the pharmacogenetics of asthma treatment.Cost-effectiveness of combination therapy for chronic obstructive pulmonary diseaseMometasone furoate/formoterol in the treatment of persistent asthma.Treating the small airways.Enhancing nuclear translocation: perspectives in inhaled corticosteroid therapy.Targeting key proximal drivers of type 2 inflammation in disease.Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations.Human tau may modify glucocorticoids-mediated regulation of cAMP-dependent kinase and phosphorylated cAMP response element binding protein.Synergistic effects of fluticasone propionate and salmeterol on inhibiting rhinovirus-induced epithelial production of remodelling-associated growth factors.Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.Fluticasone and ibuprofen do not add to the effect of salmeterol on organic dust-induced airway inflammation and bronchial hyper-responsiveness.Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challenge.Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.Changes in lymphocyte glucocorticoid and beta-adrenergic receptors in veal calves treated with clenbuterol and steroid hormones for growth-promoting purposes.Reducing airways inflammation to prevent exacerbations in chronic obstructive pulmonary disease.Corticosteroid and long-acting ß-agonist therapy reduces epithelial goblet cell metaplasia.Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma.
P2860
Q33636430-F32F77A6-C743-42E9-8AB5-6DF7F968B37CQ33858965-3BF4C731-080A-4D8F-88F2-D1754E92CA71Q34414680-8C302C2F-D679-4D21-994C-62CBF7488ADEQ35388280-312359CF-A39B-4365-9CD3-1EE98ADEA2FAQ36225454-31F91249-A2FB-4A32-911B-47059B73C5ECQ36433595-A3A3BE37-941E-4C9B-8660-5E9EB15BED5AQ37192340-D03B6A74-BAED-4EF1-9163-39B88C9C5940Q37955923-A128F4C6-A6EA-49F0-8618-46252FB49360Q38060087-88E3A507-D1E7-43AA-A1F1-4AEEE5D61831Q38495012-41D1FC49-D3E3-499C-BD71-092C178EF670Q38608260-39FF2230-6BEA-4DCC-B6C5-C05B88811681Q38930261-3D2B9591-0594-4A2C-A279-61D6A4DE1D06Q39403431-796DA13F-46EF-405A-8C26-18F1C53A2860Q40225104-4C5E9E10-6E8C-4035-9D6A-242B564C9B46Q46057464-FCC3B2FA-6CEA-4478-8731-F7FD2FDCB578Q46734942-2A207737-5274-4CBB-8D5E-050243DD03B0Q46787784-DCC670FB-B9D1-451C-8CD0-4BB306DF23F5Q46902397-DF95824E-90A8-40B6-BFCE-36BFA0F6D95AQ46974280-5329664D-3C2C-4ECA-843E-FE714B6423A9Q47718396-009E07E1-FCA2-4F82-8C59-06478FA25891Q47818177-E0FC85BE-ACFC-4A1B-AC55-84D6C71D3658Q48496612-3DD25F81-8497-40C6-B509-975F2AE1FCE6
P2860
Molecular interactions between glucocorticoids and long-acting beta2-agonists.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Molecular interactions between glucocorticoids and long-acting beta2-agonists.
@ast
Molecular interactions between glucocorticoids and long-acting beta2-agonists.
@en
type
label
Molecular interactions between glucocorticoids and long-acting beta2-agonists.
@ast
Molecular interactions between glucocorticoids and long-acting beta2-agonists.
@en
prefLabel
Molecular interactions between glucocorticoids and long-acting beta2-agonists.
@ast
Molecular interactions between glucocorticoids and long-acting beta2-agonists.
@en
P356
P1476
Molecular interactions between glucocorticoids and long-acting beta2-agonists
@en
P2093
Kittipong Maneechotesuwan
Omar Usmani
P304
P356
10.1067/MAI.2002.129705
P407
P433
P577
2002-12-01T00:00:00Z